Collaborations Pharmaceuticals
US-based company pioneering R&D for innovative treatments for rare and infectious diseases.
Founded
2015US-based company pioneering R&D for innovative treatments for rare and infectious diseases.
Founded in Raleigh, United States, Collaborations Pharmaceuticals is dedicated to pioneering research and development for innovative treatments targeting rare and infectious diseases. The company's core mission is to transform chemistry and enrich lives by leveraging both real intelligence and artificial intelligence. Their focus is on developing clinical candidates for rare, neglected, and unmet therapeutic needs, as well as creating new molecules for consumer product applications.
Collaborations Pharmaceuticals has garnered attention for its cutting-edge approach and notable affiliations with key figures in the pharmaceutical and biotech industries. The company has achieved significant milestones in advancing therapeutic candidates through various stages of development. Its impact is marked by contributions to addressing critical gaps in treatment options for rare and infectious diseases, thereby improving patient outcomes and advancing medical science.
Companies similar to Collaborations Pharmaceuticals include Confluence Pharmaceuticals, Aria Pharmaceuticals, Collaborative Medicinal Development and Edison Pharmaceuticals.
Collaborations Pharmaceuticals was founded in 2015.
Collaborations Pharmaceuticals' headquarters is located in Raleigh, NC, US.
Collaborations Pharmaceuticals' most recent funding round was for $75k (USD) in September 2022.
As of Sep 22, 2022, Collaborations Pharmaceuticals has disclosed funding of $75k (USD). Undisclosed round amounts are excluded.
Collaborations Pharmaceuticals has 11 employees as of Feb 4, 2024.
Edison Pharmaceuticals
